Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker TXG
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Shehnaaz Suliman Affiliate | TXG 10x Genomics, Inc. | 5,723 | $452.7K | 10b5-1 | Sep 22, 2026 | Form 4 ↗ 2 days later · 5,723 shares | Form 144 ↗ |
| Sep 9, 2026 | Adam Taich Officer | TXG 10x Genomics, Inc. | 46,388 | $3.0M | 10b5-1 | Sep 9, 2026 | Form 4 ↗ 2 days later · 46,388 shares | Form 144 ↗ |
| Sep 3, 2026 | John R. Stuelpnagel Director | TXG 10x Genomics, Inc. | 20,000 | $1.2M | — | Sep 3, 2026 | Form 4 ↗ 5 days later · 20,000 shares | Form 144 ↗ |
| Aug 26, 2026 | Serge Saxonov Director, CEO | TXG 10x Genomics, Inc. | 35,486 | $2.2M | 10b5-1 | Aug 26, 2026 | Form 4 ↗ 2 days later · 10,486 shares | Form 144 ↗ |
| Aug 24, 2026 | Adam Taich Officer | TXG 10x Genomics, Inc. | 16,614 | $1.1M | — | Aug 24, 2026 | Form 4 ↗ 2 days later · 17,166 shares | Form 144 ↗ |
| Aug 24, 2026 | Shehnaaz Suliman Affiliate | TXG 10x Genomics, Inc. | 2,207 | $143.7K | 10b5-1 | Aug 24, 2026 | Form 4 ↗ 2 days later · 2,207 shares | Form 144 ↗ |
| Aug 24, 2026 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 17,948 | $1.2M | — | Aug 24, 2026 | Form 4 ↗ 2 days later · 18,545 shares | Form 144 ↗ |
| Aug 24, 2026 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 13,373 | $870.8K | — | Aug 24, 2026 | Form 4 ↗ 2 days later · 13,818 shares | Form 144 ↗ |
| Aug 14, 2026 | Sarah A Polonius-Teichmann Director | TXG 10x Genomics, Inc. | 2,273 | $129.9K | 10b5-1 | Aug 14, 2026 | Form 4 ↗ 3 days later · 7,551 shares | Form 144 ↗ |
| Aug 13, 2026 | Sarah A Polonius-Teichmann Director | TXG 10x Genomics, Inc. | 5,278 | $302.4K | 10b5-1 | Aug 13, 2026 | Form 4 ↗ 4 days later · 7,551 shares | Form 144 ↗ |
| Aug 11, 2026 | John R. Stuelpnagel Director | TXG 10x Genomics, Inc. | 20,000 | $1.2M | — | Aug 11, 2026 | Form 4 ↗ 2 days later · 20,000 shares | Form 144 ↗ |
| Jun 16, 2026 | Shehnaaz Suliman Affiliate | TXG 10x Genomics, Inc. | 5,723 | $184.4K | 10b5-1 | Jun 16, 2026 | Form 4 ↗ 2 days later · 5,723 shares | Form 144 ↗ |
| May 26, 2026 | Serge Saxonov Director, CEO | TXG 10x Genomics, Inc. | 40,718 | $964.2K | 10b5-1 | May 26, 2026 | Form 4 ↗ 1 day later · 10,718 shares | Form 144 ↗ |
| May 22, 2026 | Adam Taich Officer | TXG 10x Genomics, Inc. | 11,779 | $290.7K | — | May 22, 2026 | Form 4 ↗ 5 days later · 15,098 shares | Form 144 ↗ |
| May 22, 2026 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 17,948 | $443.0K | — | May 22, 2026 | Form 4 ↗ 5 days later · 28,893 shares | Form 144 ↗ |
| May 22, 2026 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 9,430 | $232.7K | — | May 22, 2026 | Form 4 ↗ 5 days later · 11,595 shares | Form 144 ↗ |
| Mar 2, 2026 | Serge Saxonov Director, CEO | TXG 10x Genomics, Inc. | 41,152 | $910.7K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 16,152 shares | Form 144 ↗ |
| Feb 25, 2026 | Sarah A Polonius-Teichmann Director | TXG 10x Genomics, Inc. | 7,579 | $147.1K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 2 days later · 7,579 shares | Form 144 ↗ |
| Feb 23, 2026 | Adam Taich Officer | TXG 10x Genomics, Inc. | 9,188 | $176.3K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 8,968 shares | Form 144 ↗ |
| Feb 23, 2026 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 10,129 | $194.4K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 9,632 shares | Form 144 ↗ |
| Feb 23, 2026 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 8,301 | $159.3K | — | Feb 23, 2026 | Form 4 ↗ 2 days later · 7,826 shares | Form 144 ↗ |
| Nov 24, 2025 | Adam Taich Officer | TXG 10x Genomics, Inc. | 11,312 | $207.5K | — | Nov 24, 2025 | Form 4 ↗ 1 day later · 11,888 shares | Form 144 ↗ |
| Nov 24, 2025 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 13,096 | $240.2K | — | Nov 24, 2025 | Form 4 ↗ 1 day later · 13,261 shares | Form 144 ↗ |
| Nov 24, 2025 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 7,392 | $135.6K | — | Nov 24, 2025 | Form 4 ↗ 1 day later · 8,283 shares | Form 144 ↗ |
| Aug 22, 2025 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 9,228 | $123.7K | — | Aug 22, 2025 | Form 4 ↗ 4 days later · 9,348 shares | Form 144 ↗ |
| Aug 22, 2025 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 7,393 | $99.1K | — | Aug 22, 2025 | Form 4 ↗ 4 days later · 7,486 shares | Form 144 ↗ |
| Aug 22, 2025 | Adam Taich Officer | TXG 10x Genomics, Inc. | 22,037 | $295.5K | — | Aug 22, 2025 | Form 4 ↗ 4 days later · 22,315 shares | Form 144 ↗ |
| May 22, 2025 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 7,392 | $67.1K | — | May 22, 2025 | Form 4 ↗ 5 days later · 7,485 shares | Form 144 ↗ |
| May 22, 2025 | Adam Taich Officer | TXG 10x Genomics, Inc. | 3,994 | $36.3K | — | May 22, 2025 | Form 4 ↗ 5 days later · 4,044 shares | Form 144 ↗ |
| May 22, 2025 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 9,227 | $83.8K | — | May 22, 2025 | Form 4 ↗ 5 days later · 9,343 shares | Form 144 ↗ |
| Feb 28, 2025 | Serge Saxonov Director, CEO | TXG 10x Genomics, Inc. | 7,942 | $83.9K | 10b5-1 | Feb 28, 2025 | Form 4 ↗ 4 days later · 7,942 shares | Form 144 ↗ |
| Feb 24, 2025 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 5,104 | $59.0K | — | Feb 24, 2025 | Form 4 ↗ 2 days later · 5,092 shares | Form 144 ↗ |
| Feb 24, 2025 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 4,563 | $52.7K | — | Feb 24, 2025 | Form 4 ↗ 2 days later · 4,573 shares | Form 144 ↗ |
| Nov 22, 2024 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 5,734 | $76.4K | — | Nov 22, 2024 | Form 4 ↗ 3 days later · 5,807 shares | Form 144 ↗ |
| Nov 22, 2024 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 6,608 | $88.0K | — | Nov 22, 2024 | Form 4 ↗ 3 days later · 6,693 shares | Form 144 ↗ |
| Aug 22, 2024 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 6,749 | $155.3K | — | Aug 22, 2024 | — | Form 144 ↗ |
| Aug 22, 2024 | Justin J. McAnear Officer | TXG 10x Genomics, Inc. | 2,961 | $68.1K | — | Aug 22, 2024 | — | Form 144 ↗ |
| Aug 22, 2024 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 4,351 | $100.1K | — | Aug 22, 2024 | — | Form 144 ↗ |
| May 22, 2024 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 4,037 | $100.2K | — | May 22, 2024 | — | Form 144 ↗ |
| May 22, 2024 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 5,043 | $125.2K | — | May 22, 2024 | — | Form 144 ↗ |
| May 22, 2024 | Justin J. McAnear Officer | TXG 10x Genomics, Inc. | 2,899 | $72.0K | — | May 22, 2024 | — | Form 144 ↗ |
| Mar 4, 2024 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 4,660 | $217.6K | — | Mar 4, 2024 | — | Form 144 ↗ |
| Feb 22, 2024 | Saxonov Serge Officer, Director | TXG 10x Genomics, Inc. | 2,787 | $132.3K | — | Feb 22, 2024 | — | Form 144 ↗ |
| Feb 22, 2024 | Justin J. McAnear Officer | TXG 10x Genomics, Inc. | 1,842 | $87.4K | — | Feb 22, 2024 | — | Form 144 ↗ |
| Feb 22, 2024 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 2,581 | $122.5K | — | Feb 22, 2024 | — | Form 144 ↗ |
| Jan 16, 2024 | Serge Saxonov Affiliate | TXG 10x Genomics, Inc. | 20,000 | $890.2K | 10b5-1 | Jan 16, 2024 | — | Form 144 ↗ |
| Dec 14, 2023 | Serge Saxonov Affiliate | TXG 10x Genomics, Inc. | 2,000 | $110.3K | 10b5-1 | Dec 14, 2023 | — | Form 144 ↗ |
| Nov 22, 2023 | Saxonov Serge Officer | TXG 10x Genomics, Inc. | 7,480 | $324.8K | — | Nov 22, 2023 | — | Form 144 ↗ |
| Nov 22, 2023 | Justin J. McAnear Officer | TXG 10x Genomics, Inc. | 1,656 | $71.9K | — | Nov 22, 2023 | — | Form 144 ↗ |
| Nov 22, 2023 | Benjamin J. Hindson Officer, Director | TXG 10x Genomics, Inc. | 3,407 | $147.9K | — | Nov 22, 2023 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:40 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances